What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Gene
Breast cancer, Internal medicine, Genome-wide association study, Oncology and Genetics are her primary areas of study.
Her study with Breast cancer involves better knowledge in Cancer.
Her study on Internal medicine is mostly dedicated to connecting different topics, such as Endocrinology.
Her Genome-wide association study research is multidisciplinary, incorporating perspectives in Genotyping, Genetic association and Bioinformatics.
Her Oncology research is multidisciplinary, relying on both TOX3, Serous fluid, Proportional hazards model, Triple-negative breast cancer and Prostate cancer.
Her study focuses on the intersection of Genetics and fields such as Cancer research with connections in the field of Metastasis and Tumor progression.
Her most cited work include:
- Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (951 citations)
- Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations (902 citations)
- Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. (836 citations)
What are the main themes of her work throughout her whole career to date?
Jenny Chang-Claude mainly focuses on Internal medicine, Oncology, Breast cancer, Colorectal cancer and Cancer.
Her work deals with themes such as Single-nucleotide polymorphism and Genotype, which intersect with Internal medicine.
In her study, Serous fluid is inextricably linked to Ovarian cancer, which falls within the broad field of Oncology.
Her Breast cancer research includes themes of Endocrinology, Gynecology, Cohort study and Risk factor.
The study incorporates disciplines such as Gastroenterology, Cancer research, Microsatellite instability and Stage in addition to Colorectal cancer.
She has researched Cancer in several fields, including Lung cancer, Mendelian randomization and Cohort.
She most often published in these fields:
- Internal medicine (79.24%)
- Oncology (63.87%)
- Breast cancer (53.26%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (79.24%)
- Oncology (63.87%)
- Colorectal cancer (37.71%)
In recent papers she was focusing on the following fields of study:
Jenny Chang-Claude mostly deals with Internal medicine, Oncology, Colorectal cancer, Breast cancer and Odds ratio.
Her Internal medicine course of study focuses on Single-nucleotide polymorphism and Ovarian cancer.
Her work is dedicated to discovering how Oncology, Genome-wide association study are connected with Genetic association, Medical genetics and Germline and other disciplines.
Her Colorectal cancer research incorporates elements of Cancer research, Mendelian randomization, Epidemiology, Microsatellite instability and Disease.
Jenny Chang-Claude studies Estrogen receptor which is a part of Breast cancer.
Her Odds ratio study combines topics in areas such as Logistic regression, Lower risk, Menarche, Obstetrics and Confounding.
Between 2017 and 2021, her most popular works were:
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)
- Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. (208 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Her main research concerns Internal medicine, Oncology, Colorectal cancer, Genome-wide association study and Breast cancer.
Her study in Internal medicine concentrates on Odds ratio, Cancer, Case-control study, Prospective cohort study and Confidence interval.
Her Oncology research integrates issues from Epidemiology, Proportional hazards model, Disease, Hazard ratio and Stage.
Her Colorectal cancer research incorporates themes from Population study, Microsatellite instability, Aspirin, Cohort and Cancer immunology.
Her work carried out in the field of Genome-wide association study brings together such families of science as Genetic association and Medical genetics.
Her research integrates issues of CHEK2, Radiation therapy and Prostate cancer in her study of Breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
